Australia markets closed

Replimune Group, Inc. (REPL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
7.64-0.17 (-2.18%)
At close: 04:00PM EDT
7.70 +0.06 (+0.79%)
Pre-market: 08:17AM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/03/2024
31/03/2023
31/03/2022
31/03/2021
31/03/2020
Total revenue
0
0
0
0
0
-
Operating expenses
Research development
174,963
174,963
126,527
79,545
56,754
-
Selling general and administrative
59,810
59,810
50,553
38,769
23,201
-
Total operating expenses
232,853
232,853
174,166
115,144
77,148
-
Operating income or loss
-232,853
-232,853
-174,166
-115,144
-77,148
-
Interest expense
6,660
6,660
4,160
2,223
3,060
-
Total other income/expenses net
24,127
24,127
4,330
-669
-662
-
Income before tax
-215,386
-215,386
-173,996
-118,036
-80,870
-
Income tax expense
408
408
288
0
-
-
Income from continuing operations
-215,794
-215,794
-174,284
-118,036
-80,870
-
Net income
-215,794
-215,794
-174,284
-118,036
-80,870
-
Net income available to common shareholders
-215,794
-215,794
-174,284
-118,036
-80,870
-
Basic EPS
-2.85
-
-2.99
-2.26
-1.75
-1.54
Diluted EPS
-2.85
-
-2.99
-2.26
-1.75
-1.54
Basic average shares
54,847
-
58,213
52,212
46,249
34,262
Diluted average shares
54,847
-
58,213
52,212
46,249
34,262